Rules for clinical monitoring software

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org

2 posts / 0 new
Last post
Renu Bajwa
Renu Bajwa's picture
Offline
Last seen: 1 year 3 months ago
Joined: 04/21/2016 - 13:45
Rules for clinical monitoring software

For anyone using clinical survillance tech (e.g., Sentri7, VigiLanz, etc.), in addition to the fundamentals, what rules have you built for ADE monitoring/prevention? What cost savings, regulatory, or less common rules have you been able to create to enhance patient care and data capture?

I am currently using Sentri7. Items I have expanded our rules out to include:
-Antidotes, including those for extravasation. Added to trigger drugs.
-Added our IV to PO policy drugs for continual pharmacist driven route changes.
-Pregnancy CI drugs.
-Clozapine is rarely used so everyone forgets all the details around it. Added in temp, cardiac, and omission of doses to assist monitoring.
-Have a SNF as part of the health system, so BEERs criteria, psychoactive meds, etc. that CMS focuses on.